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Renal artery stenosis after kidney transplantation: Diagnostic
and therapeutic approach. Transplant renal artery stenosis
(TRAS) is a common complication after transplantation and an
important cause of graft dysfunction. Many factors have been
implicated as possible causes of TRAS, such as damage from
trauma and atherosclerosis. We reviewed all 286 patients trans-
planted in our unit from January 1990 to July 1997 to study the
prevalence, clinical features, and diagnostic and therapeutic ap-
proach. Thirteen patients with TRAS were identified, and their
mean age was 40 6 15 years. The detected incidence was 4.5%.
They were treated with triple therapy (prednisone, azathioprine
and cyclosporine A). The mean age of the donors was 28 6 27
years. TRAS was diagnosed within nine months after transplant.
All patients were studied with Doppler ultrasound, renography
with captopril and angiography. The preferred initial therapy was
percutaneous transluminal balloon renal angioplasty. Angioplasty
was performed in four patients with good results. Two patients
underwent surgery because angioplasty was not possible. Blood
pressure control could be achieved with less antihypertensive
medication after angioplasty. Transplantectomy was performed in
one patient because of surgical complications. In conclusion, most
patients with TRAS can be treated successfully with percutaneous
transluminal angioplasty as the initial interventional treatment of
choice for high-grade renal artery stenosis, and surgical revascu-
larization is indicated when percutaneous transluminal angio-
plasty cannot be done or is unsuccessful.
Hypertension is a recognized complication following
renal transplantation, occurring in approximately 60% of
recipients with long-term functioning grafts [1]. Post-trans-
plant hypertension correlates negatively with graft survival,
and is a major risk factor for accelerated cardiovascular
disease and mortality after renal transplantation [2]. The
etiology of hypertension after transplantation is multiple
and includes many conditions, such as acute and chronic
rejection, steroid therapy, cyclosporine therapy, diseased
native kidneys, recurrence of original renal disease, essential
hypertension and transplant renal artery stenosis (TRAS) [3].
Of these conditions, renal artery stenosis represents a poten-
tially curable cause of post-transplant hypertension.
Renal artery stenosis is a well-known cause of post-
transplant hypertension that can result in renal allograft
dysfunction [4, 5]. The reported incidence of post-trans-
plant RAS in different series ranged from 1 to 12%
depending on the definition of the degree of significant
stenosis and on indications for arteriography [1]. In relation
to the arterial anastomotic site, the stenosis can be proxi-
mal due to recipient atherosclerotic arterial disease, anas-
tomotic or distal in the donor renal artery [1]. Anastomotic
stenosis is usually regarded as of technical origin due to a
faulty surgical technique and/or to postoperative fibrosis
[1]. The etiology of distal stenosis is less clear, but it may be
related to mechanical or immunological damage [1]. An
early diagnosis of TRAS is important, in order to reduce
associated morbidity and mortality. Although arteriography
is the definitive diagnostic method, new noninvasive proce-
dures such as Doppler ultrasonography and scintigraphy
with captopril seem to be useful for the screening of this
pathology [6].
Three different treatment modalities are currently avail-
able for patients with transplant RAS. (1) Medical man-
agement may be effective in controlling hypertension, but
its effect on kidney function is not known. (2) Percutaneous
transluminal balloon angioplasty has received considerable
attention as a noninvasive treatment approach [1], but the
long-term effects on blood pressure control and renal
function have not been well studied. (3) Surgical revascu-
larization may be successful in treating TRAS, but this is a
major operation with associated morbidity [1]. We have
reviewed our experience with TRAS to assess the long-term
outcome of different treatment modalities on blood pres-
sure control and kidney function.
METHODS
In a series of 286 consecutive heterotopical cadaveric
kidney transplants, performed in our service between Jan-
uary 1990 and July 1997, a total of 13 (4.5%) episodes of
Key words: transplant renal artery stenosis, blood pressure, graft dysfunc-
tion, atherosclerosis, blood pressure, angioplasty.
© 1998 by the International Society of Nephrology
Kidney International, Vol. 54, Suppl. 68 (1998), pp. S-99–S-106
S-99
RAS occurred. The mean age of the recipients was 40 6 15
years, and all of them were males. They were treated with
triple therapy (prednisone, azathioprine and cyclosporine
A). The mean age of the donors was 28 6 27 years; 46% of
them were younger than 10 years and 39% were older than
50 years. Anastomosis of the allograft renal artery to the
host artery was performed by an end-to-side technique to
the external iliac artery. Renal artery stenosis was sus-
pected in patients with new or worsening hypertension.
Four patients with severe transplant renal artery stenosis
showed recurrent episodes of acute pulmonary edema.
Color flow Doppler ultrasound and captopril renography
were performed in all patients according to an established
diagnostic protocol. Color flow Doppler was performed
right before captopril renography to search for turbulences
and increased systolic velocities in the renal artery and
intrarenal vessels. The scintigraphic procedure was per-
formed by administering an oral dose of captopril 50 mg
one hour before injecting approximately 111 MBq of
99mTc-MAG3. Blood pressure was then monitored and oral
hydration was performed. Furosemide 20 mg were admin-
istered intravenously at the time of the radiotracer injection
to prevent possible false positive results secondary to tracer
retention in the renal pelvis. A baseline scintigraphy was
performed in order to compare with the captopril renog-
raphy. Renal artery stenosis was assessed by angiography
and, if a significant lesion was found, interventional treat-
ment was performed (angioplasty and/or surgery). Medi-
cally uncontrolled hypertension was required to treat
TRAS. The average length of follow-up from graft to
diagnosis of TRAS was nine months.
RESULTS
Doppler ultrasound showed the presence of a focal
stenosis in the graft artery in all 13 cases with suspected
renal artery stenosis (Fig. 1). In four of these cases,
renography with captopril was negative, and the remaining
nine patients showed changes in the scintigraphy (Figs. 2
and 3). Arteriography was performed in all patients. Ste-
nosis was at the anastomotic site in nine patients, whereas
a post-anastomotic stenosis was seen in the other four
patients (Fig. 4). The grade of the stenosis was greater than
50% in seven patients (54%). Antihypertensive medication
Fig. 1. Renal artery stenosis. Doppler spectrum showing focal elevated peak systolic velocity (faster than 200 cm/second) with mild spectral broadening
at the anastomosis.
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required to maintain blood pressure under control in-
creased with time (Fig. 5). Evolution of graft function is
shown in Figure 6. Four patients were treated with percu-
taneous transluminal angioplasty; in three of these patients
the stenosis was resolved, while the remaining one showed
no change after the treatment. In the three patients in
which stenosis was resolved, blood pressure control im-
proved. Primary surgical treatment was indicated in two
patients because angioplasty was not possible. Two patients
underwent surgical revascularization for renal artery steno-
sis with postoperative improvement of hypertension in one
and a failure in the other due to surgical complications, and
finally the graft was nephrectomized.
The renal artery stenosis was higher in cadaveric donor
kidneys from pediatric and elderly donors (46% and 38%;
Fig. 7). Seven patients underwent primary medical treat-
ment for renal artery stenosis because stenosis was smaller
than 50%, with a successful result to date.
Renal function improved, since serum creatinine was
2.4 6 0.2 mg/dl before treatment and 1.3 6 0.3 mg/dl after
treatment.
DISCUSSION
Renal artery stenosis is a relatively common cause of
refractory hypertension and allograft dysfunction in renal
transplant patients, and it is potentially curable. Its inci-
dence rate ranges from 1% to 23% [7–11]. The incidence of
TRAS in our center was 4.5%, and in recent reports has
ranged from 1.5% to 7%, a typical number being 5.5% [12],
but it is likely that it is not functionally active in all cases.
The use of color Doppler ultrasonography is useful for
early detection of TRAS [13].
The most common presentation is severe hypertension
with or without allograft dysfunction that becomes appar-
ent from three months to two years after renal transplan-
tation [7, 14]. If angiotensin-converting (ACE) inhibitors
are used, they may cause impaired renal function, severe
hypotension, or even acute renal failure [15]. The presence
Fig. 2. Baseline scintigraphy in a kidney transplanted patient with renovascular hypertension.
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of a bruit may be of little diagnostic value [14, 16], since a
significant TRAS can also occur in the absence of an
audible bruit [7].
Color flow Doppler ultrasound is the screening proce-
dure of choice, and it can have a high sensitivity and
specificity, but an experienced operator is required. A
positive screening test or severe hypertension are indica-
tions for angiography. Transplant renal artery stenosis
greater than 50% is functionally active in some, but not all,
cases. However, the success rate is variable, with significant
improvement as judged by angiography usually in 60% to
80% of patients, but with relapse in up to 30% [14, 17].
Relapse can be treated by repeat angioplasty with or
without stent implantation. Following angioplasty, color
Doppler is a useful technique for follow-up. Severe TRAS has
been reported as a cause of recurrent pulmonary edema in
transplant patients with normal cardiac function [18].
Stenosis of the anastomosis may be secondary to the
suture technique and has been more commonly observed
after end-to-end arterial anastomosis [19–21]. This compli-
cation is rare when a Carrel patch of the donor aorta is used
for end-to-side anastomosis to the external iliac artery [14,
20, 22]. However, no differences have been found in the
incidence of transplant renal artery stenosis when compar-
ing end-to-end versus end-to-side anastomosis [10, 11, 23].
Support for an immunologic cause has come from both
experimental and human studies [7, 24–26]. In grafts from
HLA-identical living related donors a similar incidence of
TRAS as in cadaveric donor grafts has also been found,
arguing against immunological factors as a major etiologic
determinant [10, 12, 17]. Finally, cyclosporine A has been
implicated in the TRAS, with resolution after cyclosporine
withdrawal [27].
Plasma renin levels must be interpreted carefully in TRAS
[7, 28], since specificity is low [29], and selective measurement
of plasma renin levels has several disadvantages [30]. Finally,
renin hypersecretion from the kidney transplant can be found
in rejection without renal artery stenosis [31].
Duplex and color-flow Doppler ultrasound are highly
sensitive, with a high specificity and a positive predictive
value, but angiographic confirmation is still required [32]
and the assessment of TRAS by Doppler depends highly on
the operator skills.
Isotopic scintigraphy performed before and after a dose
Fig. 3. Post-captopril scintigraphy in a kidney transplanted patient with renovascular hypertension. Note the massive changes in the scintigraphy
curve after Captopril administration, both in the uptake and excretory phases.
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of Captopril has a reported sensitivity of 75% but a
specificity of 67% [33]. However, Shamlou et al reported
Captopril renography to be highly predictive for physiolog-
ically significant renal artery stenosis [30].
The gold standard for diagnosing TRAS is selective graft
arteriography, but unfortunately this is associated with
contrast-induced renal failure and hypersensitive reactions
[33, 34]. In transplant patients there are no reports of
contrast-induced acute renal failure [25, 33, 35]. Spiral
computed tomography can provide satisfactory three-di-
mensional reconstruction of vessels, avoids arterial punc-
ture and requires less intravenous contrast than conven-
tional angiography [36]. Magnetic resonance angiography is
less reliable [37]. Carbon dioxide angiography can be
successfully used to visualize the stenosis as a preferred
imaging technique, as it avoids nephrotoxicity and hyper-
sensitivity reactions [38]. Magnetic resonance imaging is a
useful diagnostic test, as is spiral computed tomography
[39], but both these investigations are expensive and not
universally available.
Although spontaneous regression of TRAS has been
reported [26, 38, 40], most patients experience poorly
controlled hypertension and worsening allograft function
[23, 41]. The preferred initial mode of therapy is percuta-
neous transluminal balloon renal angioplasty (PTRA) [10,
17, 28, 42]. The procedure achieves either a cure or an
improvement in 76% of cases [10, 42] associated with
discontinuation of a least two antihypertensive medica-
tions, and some patients who had been on dialysis recov-
ered renal transplant function [11, 43, 44]. Lower success
rates have been reported, and may be related to center
experience or the type of lesion [9, 43, 44].
Despite the efficacy and safety of PTRA, complications
may occur in up to 10% of cases, including hematoma at
the femoral artery puncture site, intimal flaps, arterial
rupture, arterial dissection, and thrombosis [26, 43], graft
loss or mortality [9]. It is recommended to have a surgeon
available during the procedure who is prepared to operate
immediately should a surgical emergency occur.
PTRA is usually recommended as the procedure of
choice for TRAS that are short, linear, and relatively
distal from the anastomosis [26]. For stenoses at the
anastomosis line (usually end-to-end renal artery to
internal iliac artery), this procedure has a lower rate of
success [44] and carries a high risk of complication [21].
It has been recommended that these patients should be
Fig. 4. A stenosis of the renal artery after end-
to-side anastomosis of the renal artery to the
external iliac artery.
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treated surgically [9, 21]. However, this experience is not
universal [10, 42].
Recurrent renal artery stenosis does occur, with rates
between 10% and 33% [10, 17, 26, 42, 43]. However, PTRA
can be repeated, and a repair procedure can maintain
long-term improvement. Metallic stents have been recently
used to treat recurrent TRAS, but the experience is limited,
and their use was not without complications [45].
Indeed, for many years surgical correction was the only
treatment option for TRAS. Patients who have unsuccess-
ful angioplasty, or stenoses that are very severe or inacces-
sible to PTRA, may require surgical intervention [14].
Surgery carries a significant risk of graft loss, ureteral
injury, reoperation and mortality [10–12, 19, 43]. In gen-
eral, however, surgery has been successful, and correction
rates ranging from 63% to 92% have been reported [7, 9,
19, 23, 26, 46].
Surgery is indicated as the primary treatment in cases of
kinking and proximal stenosis, while PTRA is preferred
when TRAS is recent, linear, and relatively distal to the
Fig. 5. The number of antihypertensive drugs increased with time evolution of transplant renal artery stenosis (TRAS). Symbols are: (f) 1 medication;
(M) 2 medications; (u) 3 medications.
Fig. 6. Serum creatinine improved after TRAS treatment. Symbols are: (f) functioning graft; gray line, creatinine level.
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anastomosis. Even with successful surgery, TRAS may
reoccur at a rate of approximately 12% [25, 26]. Occasion-
ally, retransplantation may represent a simpler and safer
alternative to repeat surgery in these patients [5, 14].
In conclusion, these data suggest that Doppler ultra-
sound and captopril scintigraphy are accurate and reliable
tools for the diagnosis and follow-up of TRAS in kidney
transplanted patients, showing a high correlation with the
physiological changes present in the clinical course of this
disease. Patients with TRAS can be treated successfully
with percutaneous transluminal angioplasty, which is the
initial interventional procedure of choice for high grade
renal artery stenosis, while surgical revascularization is
indicated if percutaneous transluminal angioplasty cannot
be done or is unsuccessful.
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